ACI Formulations PLC (DSE:ACIFORMULA)

ACI Formulations Revenue

ACI Formulations had revenue of 1.36B BDT in the quarter ending March 31, 2026, with 4.59% growth. This brings the company's revenue in the last twelve months to 5.58B, up 11.39% year-over-year. In the fiscal year ending June 30, 2025, ACI Formulations had annual revenue of 5.17B with 4.83% growth.

• Revenue (ttm): 5.58B
• Revenue Growth: +11.39%
• P/S Ratio: 1.18
• Revenue / Employee: 5.61M
• Employees: 994
• Market Cap: 6.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	5.17B	238.61M	4.83%
Jun 30, 2024	4.94B	-24.35M	-0.49%
Jun 30, 2023	4.96B	712.39M	16.77%
Jun 30, 2022	4.25B	382.88M	9.91%
Jun 30, 2021	3.86B	440.49M	12.86%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error